Comparing Kovera Labs' public certificate records from 1 August to 10 November 2026, we found 46 certificates re-published with new dates between 3 August and 10 November. 24 changed their product name, and 16 of those are now listed under a vendor code or vendor product name, such as OBL-R3, SLYM2 and EDGE R3. 15 of the 16 are GLP-1-class or BPC-157/TB-500 certificates; the 16th, re-published on 10 November, is an SS-31 certificate now named BQ-31. On 8 of the 16 the LC-MS identification line itself changed from the compound to the code; on the other 8 the certificate body already printed the code in May 2026. Purity and net content did not change on the renamed certificates apart from three 0.01 mg differences, while two certificates that kept their names did change values.
Kovera Labs re-issued 46 certificates after our 1 August 2026 read of its
public records. The new publication dates run from 3 August to 10 November 2026.
24 of the 46 changed their product name, and 16 of those are now listed
under a vendor code or a vendor product name: OBL-R3 where the record said
retatrutide, SLYM2 where it said tirzepatide, BQ-31 where it said SS-31.
Update, 12 November 2026. This piece first reported 45 re-issues, read on
3 November. On 10 November Kovera re-published a 46th, KVR-2026-963483, a
50 mg certificate for BioQuantum Sciences, lot QC 08 10. Its product name and
LC-MS identification line changed from "SS-31" to "BQ-31". Purity (99.868%),
net content (51.63 mg) and the certified date (8 May 2026) are unchanged. The
expiration date moved from 10 May 2028 to 9 November 2028, the content
specification from "50mg ± 10%" to "~50mg", and the record now adds a heavy
metal line and separate endotoxin and heavy-metal reports. The vial photograph
on the re-issued certificate still shows a label reading SS-31. It is the first
code rename we have seen outside the GLP-1 and BPC-157/TB-500 set. The
counts below now include it: 46 re-issues, 24 name changes, 16 codes, 8
identification lines changed.
Most of the change is in the labels. On 8 of the 16 the LC-MS identification line switched from the compound to the code between Kovera's 1 August record and the new certificate. On the other 8 the certificate body already printed the code in our first capture, on 26 May 2026; only the listing label caught up. Purity and net content are unchanged on all 24 renamed certificates apart from three 0.01 mg differences. Two certificates that kept their names did change values.
How we did it: we compared Kovera's public certificate records as read on 1 August, 3 November and 10 November 2026, and the certificate files Kovera now serves. We did not order, test or submit anything, and we did not contact Kovera or any of its clients.
What changed, certificate by certificate
"Client" is the business name printed on the public certificate. "Listed as" is the product name in Kovera's record on 1 August 2026. "ID line changed" means the LC-MS identification line moved from a compound name to the code between our two reads; "no" means it already printed the code on 26 May.
| KVR | Client | Listed as (1 Aug) | Listed as now | Re-issued | ID line changed |
|---|---|---|---|---|---|
KVR-2026-5D3FC3 | Thryv Medical | Tirzepatide | SLYM2 | 1 Sep | yes |
KVR-2026-75F9DC | Thryv Medical | Tirzepatide | SLYM2 | 17 Sep | yes |
KVR-2026-89AEEB | Ion Peptide | Tirzepatide | ION-2T | 15 Oct | no |
KVR-2026-30AD88 | BioEdge Research Labs | Tirzepatide | EDGE T2 | 3 Aug | no |
KVR-2026-753B14 | BioEdge Research Labs | Tirzepatide | EDGE T2 | 3 Aug | no |
KVR-2026-118A1B | Onyx BioLabs | Retatrutide | OBL-R3 | 17 Sep | yes |
KVR-2026-AD0E47 | Onyx BioLabs | Retatrutide | OBL-R3 | 17 Sep | yes |
KVR-2026-39AAB2 | BioEdge Research Labs | Retatrutide | EDGE R3 | 3 Aug | yes |
KVR-2026-77513B | BioEdge Research Labs | Retatrutide | EDGE R3 | 3 Aug | no |
KVR-2026-CBA2DA | Zenergy | Semaglutide/Cagrilintide | ZEN-1/CAGRI | 3 Nov | no |
KVR-2026-6CFDF1 | private client | Semaglutide/Cagrilintide | a client code (not printed here) | 3 Nov | no |
KVR-2026-0F9075 | Zenergy | Retatrutide/Cagrilintide | ZEN-3/CAGRI | 3 Nov | no |
KVR-2026-BD148E | Glacier Aminos | Retatrutide/Cagrilintide | GLA-3 RT/Cagrilintide | 3 Nov | yes |
KVR-2026-09FFFA | Bio Enhanced Labs | BPC-157/TB-500 | Wolverine Blend | 3 Nov | no |
KVR-2026-FDE772 | Alpine Aminos LLC | BPC-157/TB-500 | AA-BPC-157/TB-500 | 3 Nov | yes |
KVR-2026-963483 | BioQuantum Sciences | SS-31 | BQ-31 | 10 Nov | yes |
Thirteen of the 16 are GLP-1-class compounds: five
tirzepatide, four retatrutide,
two semaglutide/cagrilintide and two
retatrutide/cagrilintide. Two are BPC-157/TB-500
blends, and one is SS-31. Most codes share a prefix with the client's
own name — EDGE for BioEdge, OBL for Onyx BioLabs, ZEN for Zenergy, ION
for Ion Peptide, GLA for Glacier Aminos, BQ for BioQuantum Sciences, AA
for Alpine Aminos, whose lot numbers also start "AA-". SLYM2 has no visible link to Thryv Medical. One of
the original identification lines, on KVR-2026-75F9DC, read "Tirzepetide",
misspelt on the certificate.
On the six blends, the component lines on the new certificate files carry the
new names too: ZEN-1 at 5.91 mg beside cagrilintide at 5.49 mg, "Pentadecapeptide"
at 10.66 mg inside the Wolverine Blend. The measured amounts match Kovera's 1
August record exactly; only the names differ.
The remaining 8 renames are abbreviations or formatting, not codes — "N-Acetyl Selank Amidate" (selank) became "NA Selank Amidate", "CJC-1295 (No DAC)/Ipamorelin" became "CJC/Ipa" or "CJC + Ipa", and one name gained "10MG" at the end. Our CJC-1295 + ipamorelin lab record reads those blend certificates in full.
What the public page shows today
On 5 November 2026 we opened two of the renamed certificates on Kovera's public verify page in a browser, read-only.
| KVR | Client (as printed) | Certified (as printed) | Product (as printed) | Also shown |
|---|---|---|---|---|
KVR-2026-118A1B | Onyx BioLabs | 05/13/2026 | OBL-R3 | batch RETA0526-20-1, labelled 20 mg |
KVR-2026-5D3FC3 | Thryv Medical | 04/30/2026 | SLYM2 | four downloadable reports: COA, endotoxin, heavy metals, rapid sterility |
Both pages loaded without an access code. The product field on 118A1B reads
OBL-R3, but its batch number still starts with "RETA".
Same lot, two codes
Two lots in the renamed set were certified for two different clients, a pattern we covered in Reta One Labs and the shared COAs.
- Lot
04202026TZ15is certified for Thryv Medical (5D3FC3) and for BioEdge Research Labs (753B14), both at 99.864% purity and 13.90 mg. One certificate now readsSLYM2, the otherEDGE T2. - Lot
04202026TZ10is certified for Thryv Medical (75F9DC) and for BioEdge (30AD88), both at 99.949% and 11.36 mg. AgainSLYM2on one,EDGE T2on the other.
Two certificates changed values
Two of the 22 re-issued certificates that kept their names did change the numbers a reader sees.
| KVR | Client | Product | Purity | Net content | Certified date | Re-issued |
|---|---|---|---|---|---|---|
KVR-2026-86672E | RemedyX Labs | GHK-Cu | 99.016% → 99.948% | 113.86 mg → 107.22 mg | 24 May → 11 Aug | 11 Aug |
KVR-2026-007B56 | Coffee and Peppers | MOTS-C | 99.978% → 99.947% | 11.58 mg → 11.52 mg | 5 Mar (unchanged) | 7 Oct |
Neither is a rename. Both belong to the in-place revision pattern we first documented in Kovera revised 57 COAs in place: the same certificate number, the same file address, new figures.
Smaller changes ran across the whole set of 46:
- Certified date. It moved on 35 of the 46. On all 26 BioEdge Research Labs certificates it now reads 3 August 2026, the re-issue day, in place of dates from 13 April to 27 July. On five of the ten 3 November certificates it moved forward by two days.
- Expiration date. New on all 46, now about two years after the re-issue.
- Content specification. The wording changed from "Xmg ± 10%" to "~Xmg" on every certificate except two that already read "~Xmg".
- Heavy metals. The new records add a "Heavy Metal Screening" line.
- Lot number. One changed:
KVR-2026-A04CA6(Instant Peptides) went from2026-0259-Eto2026-0259-F.
For 42 of the 46, the new file sits at the same address as the old one; the other four moved to a different storage folder under the same file name.
Fourteen certificates the public lookup no longer serves
Separately, Kovera's public lookup did not return these 14 certificates when we
read the records on 3 November 2026. Thirteen were first missing on 14 October;
D32CA0 is new. "Last served" is our last successful read; a dash means we only
ever saw it in our 26 May capture.
| KVR | Client | Product (as listed) | Last served |
|---|---|---|---|
KVR-2026-09EC68 | Phoenix Rising Peptides LLC | Bacteriostatic Water | — |
KVR-2026-290515 | Glacier Aminos | GHK-Cu | 1 Aug |
KVR-2026-3012C3 | Lost Coast Aminos | Bacteriostatic Water | — |
KVR-2026-43E23D | RemedyX Labs | GLP-T2 | 1 Aug |
KVR-2026-5F342A | Coffee and Peppers | Retatrutide (body: GLP-3 RT) | 1 Aug |
KVR-2026-65CAC0 | Glacier Aminos | Tesamorelin | 1 Aug |
KVR-2026-6D880D | RemedyX Labs | GLP-T2 | 1 Aug |
KVR-2026-8D024E | RemedyX Labs | GLP-R3 | — |
KVR-2026-8FA2E0 | Instant Peptides | Melanotan-2 | 1 Aug |
KVR-2026-9C7886 | RemedyX Labs | GLP-R3 | 1 Aug |
KVR-2026-AEA105 | Glacier Aminos | AHK-Cu | 1 Aug |
KVR-2026-BD6960 | private client | hGH w/dimer | 1 Aug |
KVR-2026-D32CA0 | Ion Peptide | Cerebro Protein | 1 Aug |
KVR-2026-FBD06A | Glacier Aminos | Selank | 1 Aug |
The record shows only that the lookup did not return them on 3 November. It does not say whether a certificate was withdrawn, replaced or is temporarily unavailable, and we do not guess. On 10 November 2026 the lookup still did not return any of the 14.
Dates
The re-issue dates, set beside regulatory events from the same months:
- 3 Aug — 26 BioEdge Research Labs certificates re-issued, including four of
the 16 code renames (
30AD88,753B14,39AAB2,77513B). - 7 Aug, 11 Aug — one Instant Peptides and one RemedyX Labs certificate.
- 12 Aug — Eli Lilly files six retatrutide suits against sellers (our coverage).
- 24 Aug — FDA warning letters to five research-peptide vendors.
- 1 Sep —
5D3FC3(Thryv Medical) re-issued asSLYM2. - 17 Sep — two Onyx BioLabs certificates as
OBL-R3, one Thryv Medical asSLYM2. - 7 Oct —
007B56and00BD2Cre-issued, names unchanged. - 8 Oct — Lilly files five more suits, 11 in total (our coverage).
- 15 Oct —
89AEEB(Ion Peptide) re-issued asION-2T. - 28 Oct — HHS files its peptide compounding enforcement discretion policy (our coverage).
- 3 Nov — 10 certificates re-issued, six of them code renames.
- 10 Nov —
963483(BioQuantum Sciences) re-issued asBQ-31, listed as SS-31 before.
The largest batch, 3 August, predates both the Lilly suits and the FDA letters. Twelve of the 16 code renames fall after them. Dates set side by side are not evidence of cause, and we draw no conclusion about why any certificate was re-issued.
What this means if your certificate carries a code
If the certificate for a vial you hold names a code rather than a compound:
- The molecule may not appear anywhere on it. On a coded certificate the
product field, the identification line and, on blends, the component lines can
all carry the code. Sometimes the batch prefix is the only trace — "RETA" on
OBL-R3. Codes like these are the subject of our piece on code-name catalogues, and of the GLP-3 RT naming explainer. - Ask the seller in writing. Request the compound name and its CAS number for the product you bought. A certificate cannot answer that question if it does not print the name.
- Match the KVR code at the source. Compare the KVR code on the seller's page with the record on Kovera's own site, not with a PDF the seller hosts. Our guide to verifying a peptide COA walks through the six fields worth checking.
- Date your copy. A re-issued certificate carries a new expiration date and may carry a new certified date. Save the file with the date you retrieved it, so a later version can be compared against it.
What we read, and what we did not
- Read. Kovera's public certificate records, as served on 1 August, 3
November and 10 November 2026; the certificate files Kovera served on 4
November, and the re-issued
963483file served on 10 November; our first capture of the registry on 26 May 2026; and Kovera's public verify page for two certificates on 5 November. - Not held. We do not hold copies of the earlier certificate images for the re-issued files, and Kovera replaced them at the same address. "Before" in this piece means Kovera's own earlier data record, not the earlier image.
- Not asked. We did not contact Kovera or any client named above.
- Not checked. We did not look at any client's storefront for these codes, and make no claim about what any of them sells today.
- Not tested. We placed no order and tested nothing.
We do not name the private client on KVR-2026-6CFDF1 or print its product
code.
Frequently asked
What does OBL-R3, SLYM2 or EDGE R3 mean on a Kovera certificate?
Each is the product name now printed for a client's certificate. OBL-R3 appears on two Onyx BioLabs certificates that Kovera's record listed as retatrutide on 1 August 2026. SLYM2 appears on two Thryv Medical certificates listed as tirzepatide. EDGE R3 appears on two BioEdge Research Labs certificates listed as retatrutide. The record shows the client and the former listing name. It does not explain the code.
Did Kovera change any purity or content values on the renamed certificates?
Not materially. On all 24 renamed certificates the printed purity is the same as on 1 August 2026, and net content is the same apart from three 0.01 mg differences. Two certificates that kept their names did change values: a GHK-Cu certificate moved from 99.016% to 99.948% purity and from 113.86 mg to 107.22 mg, and a MOTS-C certificate moved from 99.978% to 99.947% and from 11.58 mg to 11.52 mg.
What is BQ-31 on a Kovera certificate?
BQ-31 is the product name now printed on KVR-2026-963483, a BioQuantum Sciences certificate that Kovera's record listed as SS-31 until it was re-published on 10 November 2026. The product field and the LC-MS identification line both changed from SS-31 to BQ-31. Purity (99.868%), net content (51.63 mg) and the certified date (8 May 2026) did not change. The vial photograph on the re-issued certificate still shows a label reading SS-31. The record does not explain the code.
Can I still verify a renamed Kovera certificate?
Yes. Look it up by its KVR code on Kovera's verify page. On 5 November 2026 we opened two renamed certificates in a browser, KVR-2026-118A1B and KVR-2026-5D3FC3. Both loaded without an access code and showed the new product names, OBL-R3 and SLYM2.
Why did Kovera re-issue these certificates?
We do not know. The records show dates, not reasons. The largest batch, 26 BioEdge Research Labs certificates, was re-issued on 3 August 2026, before the August Lilly lawsuits and FDA warning letters. We have not asked Kovera or any client, and we draw no conclusion about cause.
How do I check what compound a coded certificate covers?
Ask the seller for the compound name and CAS number in writing, then match the KVR code on the seller's page against the record on Kovera's own site. A coded certificate may not name the molecule anywhere except, sometimes, in the batch prefix.